Ophthonix Presents at JP Morgan Healthcare Conference
January 12, 2006
Andreas Dreher, Ph.D., president and CEO of Ophthonix, discussed the company's proposition, strategies and direction, including the recent successful launch of the customized iZon Wavefront-Guided Eyeglasses. Dr. Dreher also provided information about a recent study on nighttime driving, which showed vision and reaction while driving at night are significantly improved with the iZon eyeglasses over conventional lenses. The study, conducted in a controlled FDA-recognized night-driving simulator demonstrated that with iZon eyeglasses a driver can identify and react to a pedestrian 25 feet sooner at 55 mph. For perspective, this is greater than two car lengths or the distance across a typical intersection.
Ophthonix Inc., a San Diego-based, venture-funded ophthalmic company, is developing exceptional vision assessment and correction technologies to greatly enhance visual acuity. Ophthonix is currently advancing a system that will improve the ability of optometrists and ophthalmologists to care for their patients and benefit the millions around the world requiring vision correction. Ophthonix is located at 10455 Pacific Center Court, San Diego, CA 92121, www.ophthonix.com, firstname.lastname@example.org, 858-869-2086.
Ophthonix is a venture-funded company supported by these premier firms:
Enterprise Partners Venture Capital
Gund Investment Corp.
Kleiner Perkins Caufield & Byers
Trex Enterprises Corp.